Replies to post #264102 on Avid Bioservices Inc (CDMO)

[tech0200]

I don't know. Most people on this board would agree that you would have to subtract billions in a PPHM sale because of management. And I don't think there is anybody on this board who wouldn't take 10 billions right now.

[biopharm]

Now since Garnick was back on the cc and we see the connections from this past post, I wonder what Peter Thiel has up his sleeve for Peregrine Pharmaceuticals

https://www.technologyreview.com/s/541226/peter-thiel-explains-biotech-investing-rationale-get-rid-of-randomness/

[biopharm]

Stanford Peng
Vice President, Clinical Development -Stemcentrx

------

Robert Garnick with Stemcentrx and Peregrine Pharmaceuticals... and gets $10 Billion from Abbvie for Stemcentrx, how much for Peregrine Pharmaceuticals / PS Targeting / Avid ???

Those PPHM shares are worth more... much more, because Stemcentrx has much less than Peregrine (Venture Capital money though.... like that of Peter Thiel)

Reshuffling a bit but it clearly stands out that Stanford Peng at Robert Garnick backed Stemcentrx and now at Alpine Immume Sciences backed by Dr Venkatesan

https://www.alpineimmunesciences.com/alpine-immune-sciences-presents-preclinical-data-on-novel-immuno-oncology-molecules-at-the-society-for-immunotherapy-of-cancers-32nd-annual-meeting/

https://www.linkedin.com/in/jay-venkatesan-7201158

http://www.alpinebioventures.com/team/

As said shuffling some puzzle pieces ....
Oct 27 2015 KITE and Alpine collaborate
April 28 2016 Abbvie buys Stemcentrx $10 Billion
Sept 25 2016 Stanford Peng brought on to Alpine Biosciences ....
Aug 28 2017 Gilead buys out Kite $12 Billion

....ok back to this later but Dr Jay Venkatesan has known about Peregrine for quite some